S
Skye Bioscience, Inc. (SKYE)
NGM – Real Time Price. Currency in USD
0.68
-0.03 (-4.02%)
At close: Jun 26, 2026, 4:00 PM EDT
0.68
+0.00 (0.01%)
After-hours: Jun 26, 2026, 7:38 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
0.68
-0.03 (-4.02%)
At close: Jun 26, 2026, 4:00 PM EDT
0.68
+0.00 (0.01%)
After-hours: Jun 26, 2026, 7:38 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $8.1M significantly exceed its total debt $311.3K, ensuring strong financial flexibility
Total current assets $18.6M exceed Total current liabilities $10.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-5,763.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$8.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.78 | 6.05 | 9.0 | |
| Quick ratio | 1.78 | 5.63 | 9.0 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | -5763.70 | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -115K | -124K | -299K | -723K | -719K |
| Operating Income | -12M | -14M | -36M | -58M | -59M |
| Net Income | -19M | -38M | -27M | -56M | -57M |
| EBITDA | -12M | -14M | -36M | -57M | -58M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 43.84 | 5.5 |
| Next quarter | N/A | 25.97 | 5.5 |
| Current year | N/A | 31.47 | 5.5 |
| Next year | N/A | -18.97 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 13.38 | 11.11 | 12.37 | 8.0 |
| Y/Y | 999 | -12.65 | -14.28 | 6.9 | 4.3 |
| 3y average | 999 | -58.08 | -3.36 | -53.98 | 3.3 |
| 5y average | 999 | -66.54 | N/A | -52.95 | 3.3 |
| Weighted average score | 4.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |